Bellevue Group AG

Holdings History for Jade Biosciences, Inc. - Common Stock, par value $0.0001 per share (JBIO)

Symbol: JBIO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 3,341,103 shares
Security Ownership %: 6.8%

Shares, Excluding Options vs Price

Value, Excluding Options

Bellevue Group AG ownership in Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO)

17 Feb 2026 - Bellevue Group AG has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,341,103 shares of Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO). This represents 6.8% ownership of the company. This is the first filing by Bellevue Group AG disclosing ownership of Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Bellevue Group AG	6.8%		$46,307,688	3,341,103			$13.86	13G	16 Dec 2025	17 Feb 2026, 16:01

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.98%	+0.98%	$51,553,219	3,341,103	+3,341,103	NEW	$15.43	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.